Recombinant structures expand and contract inter and intragenic diversification at the KIR locus

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Pyo, Chul Woo ^a   Wang, Ruihan ^a   Vu, Quyen ^a   Cereb, Nezih ^b   Yang, Soo Young ^b   Duh, Fuh Mei ^c   Wolinsky, Steven ^d   Martin, Maureen P ^c   Carrington, Mary ^c   Geraghty, Daniel E ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Histogenetics LLC   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Human; KIR; Natural killer cells; Recombinant structures

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ARTICLE; CENTROMERE; CONTROLLED STUDY; DELETION MUTANT; DNA HYBRIDIZATION; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE IDENTIFICATION; GENE LOCUS; GENETIC VARIABILITY; HAPLOTYPE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR GENE; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; TELOMERE;

ALLELES; CENTROMERE; GENE DUPLICATION; GENE FREQUENCY; HAPLOTYPES; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, KIR; TELOMERE;

EID: 84873466377     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-89     Document Type: Article

References (61)

1. Lanier LL. NK cell recognition. Annu Rev Immunol 2005, 23:225-274. 10.1146/annurev.immunol.23.021704.115526, 15771571.
2. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005, 5(3):201-214. 10.1038/nri1570, 15719024.
3. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 1998, 95(9):5199-5204. 10.1073/pnas.95.9.5199, 20238, 9560253.
4. Gunturi A, Berg RE, Forman J. The role of CD94/NKG2 in innate and adaptive immunity. Immunol Res 2004, 30(1):29-34. 10.1385/IR:30:1:029, 15258309.
5. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7(6):739-751. 10.1016/S1074-7613(00)80393-3, 9430220.
6. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002, 190:40-52. 10.1034/j.1600-065X.2002.19004.x, 12493005.
7. Wilson MJ, Torkar M, Haude A, Milne S, Jones T, Sheer D, Beck S, Trowsdale J. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A 2000, 97(9):4778-4783. 10.1073/pnas.080588597, 18309, 10781084.
8. Martin AM, Freitas EM, Witt CS, Christiansen FT. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics 2000, 51(4-5):268-280.
9. Pyo CW, Guethlein LA, Vu Q, Wang R, Abi-Rached L, Norman PJ, Marsh SG, Miller JS, Parham P, Geraghty DE. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS One 2010, 5(12):e15115. 10.1371/journal.pone.0015115, 3012066, 21206914.
10. Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin Immunol 2008, 20(6):343-352. 10.1016/j.smim.2008.06.003, 3501819, 18635379.
11. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004, 305(5685):872-874. 10.1126/science.1097670, 15297676.
12. Moraru M, Cisneros E, Gomez-Lozano N, de Pablo R, Portero F, Canizares M, Vaquero M, Roustan G, Millan I, Lopez-Botet M. Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J Immunol 2012, 188(9):4412-4420. 10.4049/jimmunol.1103434, 22490439.
13. Bashirova AA, Thomas R, Carrington M. HLA/KIR restraint of HIV: surviving the fittest. Annu Rev Immunol 2011, 29:295-317. 10.1146/annurev-immunol-031210-101332, 21219175.
14. Majorczyk E, Pawlik A, Luszczek W, Nowak I, Wisniewski A, Jasek M, Kusnierczyk P. Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis. Genes Immun 2007, 8(8):678-683. 10.1038/sj.gene.6364433, 17882223.
15. Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE, Witte T. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 2004, 50(5):1561-1565. 10.1002/art.20216, 15146426.
16. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295(5562):2097-2100. 10.1126/science.1068440, 11896281.
17. Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, Marsh SG, Geraghty D, Spellman S, Haagenson MD. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 2010, 116(14):2411-2419. 10.1182/blood-2010-05-283051, 2953880, 20581313.
18. Chazara O, Xiong S, Moffett A. Maternal KIR and fetal HLA-C: a fine balance. J Leukoc Biol 2011, 90(4):703-716. 10.1189/jlb.0511227, 21873457.
19. Chien JW, Zhang XC, Fan W, Wang H, Zhao LP, Martin PJ, Storer BE, Boeckh M. Warren EH 2012, Hansen JA: Evaluation of published single nucleotide polymorphisms associated with acute graft versus host disease. Blood.
20. Fellay J, Frahm N, Shianna KV, Cirulli ET, Casimiro DR, Robertson MN, Haynes BF, Geraghty DE, McElrath MJ, Goldstein DB. Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial. J Infect Dis 2011, 203(6):773-779. 10.1093/infdis/jiq125, 3071133, 21278214.
21. Geraghty DE, Daza R, Williams LM, Vu Q, Ishitani A. Genetics of the immune response: identifying immune variation within the MHC and throughout the genome. Immunol Rev 2002, 190:69-85. 10.1034/j.1600-065X.2002.19006.x, 12493007.
22. Pyo CW, Williams LM, Moore Y, Hyodo H, Li SS, Zhao LP, Sageshima N, Ishitani A, Geraghty DE. HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes. Immunogenetics 2006, 58(4):241-251. 10.1007/s00251-005-0076-z, 16570139.
23. Smith WP, Vu Q, Li SS, Hansen JA, Zhao LP, Geraghty DE. Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes. Genomics 2006, 87(5):561-571. 10.1016/j.ygeno.2005.11.020, 16434165.
24. Raymond CK, Subramanian S, Paddock M, Qiu R, Deodato C, Palmieri A, Chang J, Radke T, Haugen E, Kas A. Targeted, haplotype-resolved resequencing of long segments of the human genome. Genomics 2005, 86(6):759-766. 10.1016/j.ygeno.2005.08.013, 16249066.
25. Daza-Vamenta R, Glusman G, Rowen L, Guthrie B, Geraghty DE. Genetic divergence of the rhesus macaque major histocompatibility complex. Genome Res 2004, 14(8):1501-1515. 10.1101/gr.2134504, 509259, 15289473.
26. Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics 2003, 55(4):220-226. 10.1007/s00251-003-0571-z, 12838378.
27. Gordon D, Abajian C, Green P. Consed: a graphical tool for sequence finishing. Genome Res 1998, 8(3):195-202.
28. Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 1998, 8(3):175-185.
29. Bradley RK, Roberts A, Smoot M, Juvekar S, Do J, Dewey C, Holmes I, Pachter L. Fast statistical alignment. PLoS Comput Biol 2009, 5(5):e1000392. 10.1371/journal.pcbi.1000392, 2684580, 19478997.
30. Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 2002, 30(14):3059-3066. 10.1093/nar/gkf436, 135756, 12136088.
31. Martin DP, Lemey P, Lott M, Moulton V, Posada D, Lefeuvre P. RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics 2010, 26(19):2462-2463. 10.1093/bioinformatics/btq467, 2944210, 20798170.
32. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28(10):2731-2739. 10.1093/molbev/msr121, 3203626, 21546353.
33. Kohany O, Gentles AJ, Hankus L, Jurka J. Annotation, submission and screening of repetitive elements in Repbase: RepbaseSubmitter and Censor. BMC Bioinformatics 2006, 7:474. 10.1186/1471-2105-7-474, 1634758, 17064419.
34. Traherne JA, Martin M, Ward R, Ohashi M, Pellett F, Gladman D, Middleton D, Carrington M, Trowsdale J. Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum Mol Genet 2010, 19(5):737-751. 10.1093/hmg/ddp538, 2816608, 19959527.
35. Excoffier L, Lischer HE. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 2010, 10(3):564-567. 10.1111/j.1755-0998.2010.02847.x, 21565059.
36. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/HLA database. Nucleic Acids Res 2011, 39:1171-1176.
37. Smit AF. Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr Opin Genet Dev 1999, 9(6):657-663. 10.1016/S0959-437X(99)00031-3, 10607616.
38. Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens 2001, 57(1):22-31. 10.1034/j.1399-0039.2001.057001022.x, 11169255.
39. Ordonez D, Gomez-Lozano N, Rosales L, Vilches C. Molecular characterisation of KIR2DS2*005, a fusion gene associated with a shortened KIR haplotype. Genes Immun 2011, 12(7):544-551. 10.1038/gene.2011.35, 21593779.
40. Guethlein LA, Older Aguilar AM, Abi-Rached L, Parham P. Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. J Immunol 2007, 179(1):491-504.
41. Maxwell LD, Wallace A, Middleton D, Curran MD. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 2002, 60(3):254-258. 10.1034/j.1399-0039.2002.600307.x, 12445308.
42. Hou L, Chen M, Ng J, Hurley CK. Conserved KIR allele-level haplotypes are altered by microvariation in individuals with European ancestry. Genes Immun 2012, 13(1):47-58. 10.1038/gene.2011.52, 3536055, 21796155.
43. Norman PJ, Abi-Rached L, Gendzekhadze K, Korbel D, Gleimer M, Rowley D, Bruno D, Carrington CV, Chandanayingyong D, Chang YH. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet 2007, 39(9):1092-1099. 10.1038/ng2111, 17694054.
44. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 2002, 168(5):2307-2315.
45. Jiang W, Johnson C, Jayaraman J, Simecek N, Noble J, Moffatt MF, Cookson WO, Trowsdale J, Traherne JA. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res 2012, 22(10):1845-1854. 10.1101/gr.137976.112, 3460180, 22948769.
46. Martin MP, Bashirova A, Traherne J, Trowsdale J, Carrington M. Cutting edge: expansion of the KIR locus by unequal crossing over. J Immunol 2003, 171(5):2192-2195.
47. Gomez-Lozano N, Estefania E, Williams F, Halfpenny I, Middleton D, Solis R, Vilches C. The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated. Eur J Immunol 2005, 35(1):16-24. 10.1002/eji.200425493, 15580659.
48. Norman PJ, Carrington CV, Byng M, Maxwell LD, Curran MD, Stephens HA, Chandanayingyong D, Verity DH, Hameed K, Ramdath DD. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 2002, 3(2):86-95. 10.1038/sj.gene.6363836, 11960306.
49. Gomez-Lozano N, de Pablo R, Puente S, Vilches C. Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction. Eur J Immunol 2003, 33(3):639-644. 10.1002/eji.200323741, 12616484.
50. Gomez-Lozano N, Gardiner CM, Parham P, Vilches C. Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 2002, 54(5):314-319. 10.1007/s00251-002-0476-2, 12185535.
51. Ordonez D, Meenagh A, Gomez-Lozano N, Castano J, Middleton D, Vilches C. Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes. Genes Immun 2008, 9(5):431-437. 10.1038/gene.2008.34, 18480828.
52. Abi-Rached L, Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 2005, 201(8):1319-1332. 10.1084/jem.20042558, 2213150, 15837816.
53. Yawata M, Yawata N, Abi-Rached L, Parham P. Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit Rev Immunol 2002, 22(5-6):463-482.
54. Trowsdale J, Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin Immunol 2008, 20(6):317-320. 10.1016/j.smim.2008.06.002, 18656382.
55. Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, Ge D, De Luca A, Martinez-Picado J, Wolinsky SM. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol 2011, 9(11):e1001208. 10.1371/journal.pbio.1001208, 3226550, 22140359.
56. Norman PJ, Abi-Rached L, Gendzekhadze K, Hammond JA, Moesta AK, Sharma D, Graef T, McQueen KL, Guethlein LA, Carrington CV. Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res 2009, 19(5):757-769. 10.1101/gr.085738.108, 2675964, 19411600.
57. McClellan J, King MC. Genetic heterogeneity in human disease. Cell 2010, 141(2):210-217. 10.1016/j.cell.2010.03.032, 20403315.
58. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006, 4(1):e9. 10.1371/journal.pbio.0040009, 1318474, 16366734.
59. Nowak I, Majorczyk E, Ploski R, Senitzer D, Sun JY, Kusnierczyk P. Lack of KIR2DL4 gene in a fertile Caucasian woman. Tissue Antigens 2011, 78(2):115-119. 10.1111/j.1399-0039.2011.01711.x, 21623736.
60. Dohring C, Colonna M. Human natural killer cell inhibitory receptors bind to HLA class I molecules. Eur J Immunol 1996, 26(2):365-369. 10.1002/eji.1830260215, 8617305.
61. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, di Donato C, Accame L, Bottino C, Moretta A, Moretta L. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996, 184(2):505-518. 10.1084/jem.184.2.505, 2192700, 8760804.